Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 13Breast Neoplasms 9Prostatic Neoplasms 4Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Pain, Postoperative 3Ovarian Neoplasms 3Neoplasm Metastasis 3Fallopian Tube Neoplasms 3Stomach Neoplasms 2Pancreatic Neoplasms 2Lymphoma 2Hemorrhage 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thromboembolism 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Peritoneal Neoplasms 1Peripheral Nervous System Diseases 1Pancreatic Cyst 1Pain 1Non-Muscle Invasive Bladder Neoplasms 1Neurotoxicity Syndromes 1Myofibroma 1Multiple Myeloma 1Metabolic Diseases 1Melanoma 1

Interventions

Saline Solution 1Neuroprotective Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Chemotherapy-Related Cognitive Impairment × Saline Solution × Clear all
NCT05239663 2024-08-01

GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer

Sun Yat-sen University

Phase 3 Terminated
76 enrolled
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡